Search Results 201-210 of 18754 for amyloidosis

  1. Left ventricular hypertrophy - Diagnosis and treatment - Mayo Clinic

    Amyloidosis. If other treatments don't work, a stem cell transplant may be needed. Treatment for amyloidosis is available at specialized clinics. Together ...

  2. The Study Of An Investigational Drug, Patisiran (ALN-TTR02), For The Treatment Of Transthyretin (TTR)-Mediated Amyloidosis In Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran) - Mayo Clinic

    The Study Of An Investigational Drug, Patisiran (ALN-TTR02), For The Treatment Of Transthyretin (TTR)-Mediated Amyloidosis In Patients Who Have Already Been ...

  3. The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran) - Mayo Clinic

    The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been ...

  4. TRITON-PN: A Study To Evaluate The Efficacy And Safety Of Nucresiran In Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy - Mayo Clinic

    Clinical Trials · TRITON-PN: A Study To Evaluate The Efficacy And Safety Of Nucresiran In Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy.

  5. Elizabeth A. Mauricio, M.D. - Doctors and Medical Staff - Mayo Clinic

    ... amyloidosis, myopathy, muscular dystrophy, myasthenia gravis and amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease). She performs ...

  6. Publications - Dan P. Larson, M.D. - Mayo Clinic

    Dual Amyloidosis: A Clinicopathologic and Proteomic Analysis of 111 Patients. ... Gallbladder amyloidosis is often unexpected and may have systemic implications.

  7. APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis - Mayo Clinic

    APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis · Overview · Participation ...

  8. MAGNITUDE: a Phase 3 Study of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM) - Mayo Clinic

    MAGNITUDE: a Phase 3 Study of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM). Print details. Share; Facebook · Twitter.

  9. A Study to Evaluate Gut Microbiome with POEMS Syndrome and Other Plasma Cell Disorders - Mayo Clinic

    ... amyloidosis, have not been explored; and their pathophysiology is quite elusive. To help understand rare plasma cell disorders and its association with gut ...

  10. Publications - Hicham Z. El Masry, M.D. - Mayo Clinic

    Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation in Cardiac Amyloidosis. ... amyloidosis: A retrospective cohort analysis. Heart Rhythm. 2025 ...